Anavex Life Sciences Corp (AVXL)

[raja48185]

Presently there are about 78,030,000 AVXL shares in trade. I’ll presume that that number won’t change by the time blarcamesine is approved for sale and Alzheimer’s treatment therapy

Would it not be practical to assume anywhere from 10% to 20% increase in the share count - for various reasons, unless you are assuming that AVXL gets approval for AD this year?